Macopharma

Macopharma

Tourcoing, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Macopharma is a private, family-owned European leader in blood processing solutions, operating for over 45 years. The company provides an integrated portfolio of disposables, equipment, and software to blood banks and healthcare professionals, aiming to improve the safety, quality, and efficiency of blood component production. Its strategy is built on continuous innovation (its 'INNOV' process) and a strong commitment to corporate social responsibility (CSR). With a global footprint through subsidiaries, Macopharma focuses on addressing key challenges in the blood supply chain, including sustainability and supply security.

Transfusion MedicineBlood Safety

Technology Platform

Integrated blood processing solutions combining proprietary disposables (bags, filters), equipment, software, and processing protocols for the collection, separation, storage, and pathogen reduction of blood components.

Opportunities

Growing demand for sustainable blood banking solutions and pathogen reduction technologies creates a significant market.
Expansion into adjacent cell therapy manufacturing through acquisitions (e.g., GMPi group buying Lmb Technologie) opens new revenue streams in a high-growth sector.

Risk Factors

Intense competition from larger global medtech companies and vulnerability to stringent, evolving regulatory requirements across different countries.
Exposure to global supply chain disruptions and raw material cost inflation impacting manufacturing.

Competitive Landscape

Macopharma competes in a consolidated global market with major players like Terumo BCT, Fresenius Kabi, and Haemonetics. Its differentiation lies in its integrated solution approach, focus on sustainability (e.g., DEHP-free containers), and agility as a private, family-owned European specialist.